Viewing StudyNCT00158782



Ignite Creation Date: 2024-05-05 @ 11:51 AM
Last Modification Date: 2024-10-26 @ 9:15 AM
Study NCT ID: NCT00158782
Status: COMPLETED
Last Update Posted: 2017-11-17
First Post: 2005-09-08

Brief Title: Study Of Safety And Tolerability Of GW786034 Given With Lapatinib In Cancer Patients
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Conditions & Keywords Data

Conditions:
Name
Carcinoma Renal Cell
Keywords:
Name View
Cancer GW786034 Lapatinib Pazopanib View